The Office of Research on Women’s Health (ORWH) is offering administrative supplements to support research addressing health disparities among women in the United States who are underrepresented, underserved, and underreported (U3) in biomedical research.

This initiative aims to address the disproportionate burden of disease and adverse health outcomes experienced by women belonging to NIH populations with health disparities.

The ORWH encourages rigorous, collaborative, interdisciplinary research on the differential risk, treatment outcomes, and morbidity experienced by these populations of women.

Scope of Work

This NOSI encourages research on the differential risk, treatment outcomes, and morbidity experienced by populations of women who are underrepresented, underserved, and underreported in biomedical research across the lifespan.

The proposed research must address at least one objective from the strategic goals 1, 2, 4 or 5 of the NIH-Wide Strategic Plan for Research on the Health of Women 2024-2028.

The research should incorporate intersectionality and culturally and contextually relevant approaches into research by applying the NIMHD Minority Health and Health Disparities Research Framework to meet group- and population-level needs.

Eligibility

Only PDs/PIs of an active DP1, DP2, DP4, DP5, K01, K08, K23, K76, K99/R00, P01, P20, P30, P40, P41, P50, P51, P60, P2C, PM1, R01, R03, R15, R21, R24, R25, R33, R34, R35, R37, R41/R42, R43/R44, R41, R42, R43, R44, R61, RF1, RC4, RM1, S06, S11, U01, U10, U19, U2C, U24, U42, U44, U54, U56, UC2, UL1, UM1, UM2, UG1, UG3/UH3, UH2/UH3, UH2, or UP5 award from NIH are eligible to apply.

• The parent peer-reviewed NIH-funded grant must have at least 16 months of active grant support remaining from the due date.

• The proposed research must be within the scope of the parent award to meet increased costs that are within the scope of the approved award, but were unforeseen when the new or renewal application or grant progress report for non-competing continuation support was submitted.

• Only one U3 Administrative Supplement award per period of performance is permitted to a peer-reviewed NIH-funded grant.

• The proposed research must address at least one objective from the strategic goals 1, 2, 4 or 5 of the NIH-Wide Strategic Plan for Research on the Health of Women 2024-2028.

Budget and Duration

ORWH intends to commit at least $1 million annually for this program.

The application budget should not exceed $140,000 in direct costs.

Applicable F&A (indirect) costs can also be requested.

The application budget is limited to one year only.

Supplements may provide support above the dollar limits of the funding opportunity announcement of the parent grant award.

Earliest start date – August 2025.

Additional Information

Foreign Institutions are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Key Dates

Release Date: October 11, 2024

First Available Due Date: January 22, 2025

Expiration Date: January 23, 2026

For More funding Opportunities, Visit Global Funding Opportunities.